immunotherapy

1:22
Jarrod Longcor: ESMO highlights
Jarrod Longcor
1:22
Myeloma tackling combinations
Enrique Ocio
1:11
Elotuzumab with Car/Pom/Dex for high-risk R/R myeloma
James Berenson
3:28
Risk-adapted therapy in smoldering myeloma
Maria-Victoria Mateos
1:40
Key topics from IMW 2019
Maria-Victoria Mateos
1:26
EBMT guidelines CAR-T education & guidelines for nurses
Rose Ellard
1:16
CAR-T treatment journey and the role of the nurse
Rose Ellard
0:35
The importance of patient monitoring post-CAR-T treatment
Rose Ellard
1:34
CAR-T: symptoms and their assessment
Rose Ellard
8:08
CAR T-cell therapy; guidelines for nurses
Orla Stewart
2:43
Progression of multiple myeloma novel therapies with Prof. Nagler
Arnon Nagler
2:25
Increase in cancer patient transfers to the ICU: what does it come down to?
Michael von Bergwelt
1:48
Is the lack of ICU space an issue for CAR-T therapy?
Victoria Metaxa
1:35
CAR-T therapy: ethical challenges
Victoria Metaxa
2:09
May the EuroCAR-T Force be with you: improving CAR-T patient care
Victoria Metaxa
1:29
Further progression for CAR T-cell therapy?
Paolo Strati
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

The content of VJHemOnc is intended for healthcare professionals